These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4400152)

  • 21. [Alternative medication not always harmless].
    Thien T; Benneker JC
    Ned Tijdschr Geneeskd; 1994 Feb; 138(6):315. PubMed ID: 8121515
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of arterial hypertension with the hypotensive agent LA-313 B].
    Mata O
    Folia Clin Int (Barc); 1974 Dec; 24(12):883-91. PubMed ID: 4452395
    [No Abstract]   [Full Text] [Related]  

  • 23. [Reserpine derivatives and ambulatory treatment of arterial hypertension].
    Cuny G
    Sem Ther; 1967 Nov; 43(9):527-8. PubMed ID: 5623395
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of arterial hypertension with an association of reserpiline, theophylline and papaverine].
    Pauchant M; Bernard JM
    Lille Med; 1971; 17():Suppl 3:545-50. PubMed ID: 5153014
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial: Rauwolfia derivatives and cancer.
    Lancet; 1974 Sep; 2(7882):701-2. PubMed ID: 4142968
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of benign essential hypertension with an association of spironolactone and thiabutazide: an open multicenter study in general practice (author's transl)].
    Rhomberg F; Leya A
    Schweiz Rundsch Med Prax; 1981 Dec; 70(50):2269-78. PubMed ID: 7031639
    [No Abstract]   [Full Text] [Related]  

  • 27. Spironolactone and propranolol in the management of hypertension.
    Akbar fA; Pearce MY
    Br J Clin Pract; 1984 Mar; 38(3):110-4. PubMed ID: 6370284
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of essential hypertension with spironolactone with reference to the plasma renin activity].
    Esch I; Placheta P
    Wien Klin Wochenschr; 1973 Jun; 85(23):413-7. PubMed ID: 4575841
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative test of antihypertensive effects of N-diethylaminoethyl reserpine (bietaserpine) and other similar drugs].
    Murakami M; Sekimoto H; Nakat I; Iwaki N; Nakai T
    Saishin Igaku; 1971 Jan; 26(1):145-53. PubMed ID: 5539259
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of the micronized aldactone - altizide combination in the treatment of edema].
    Lekiefre J; Foucault M; Basin B; Delemotte M
    Lille Med; 1966; 11(6):730-3. PubMed ID: 5942193
    [No Abstract]   [Full Text] [Related]  

  • 31. [Testing of various doses of a non-sedative derivative of reserpine, R 694, in the therapy of arterial hypertension].
    GROS H; PETERFALVI M; JEQUIER R
    Alger Medicale; 1959 Mar; 63(3):297-8 passim. PubMed ID: 13661055
    [No Abstract]   [Full Text] [Related]  

  • 32. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H; Perret M; Etaix JP
    J Med Lyon; 1967 Feb; 48(114):173-83. PubMed ID: 5600100
    [No Abstract]   [Full Text] [Related]  

  • 33. Cryptenamine and cryptenamine plus reserpine in the treatment of arterial hypertension.
    COHEN BM; CROSS EB; JOHNSON W
    Am Pract Dig Treat; 1955 Jul; 6(7):1030-5. PubMed ID: 14388199
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on treatment of chronic fixed hypertension with a combination preparation].
    LEIMGARDT H
    Medizinische; 1958 Sep; 36(6):1406-8. PubMed ID: 13589512
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term experience of spironolactone in essential hypertension.
    Jeunemaitre X; Kreft-Jais C; Chatellier G; Julien J; Degoulet P; Plouin PF; Ménard J; Corvol P
    Kidney Int Suppl; 1988 Oct; 26():S14-7. PubMed ID: 3199684
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy of essential hypertension with Saltubol].
    Hirsch W; Gaumitz E
    Ther Ggw; 1969 Jun; 108(6):859-60 passim. PubMed ID: 5383167
    [No Abstract]   [Full Text] [Related]  

  • 37. [Spironolactone-benzothiadiazine association in the treatment of female obesity with water and salt retention].
    Plauchu M; Bourlier V; Meunier P
    Lyon Med; 1965 Sep; 214(37):363-7. PubMed ID: 5852197
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experiences in the treatment of hypertension in diabetic patients].
    Schulz-Merkel D; Franke P
    Med Monatsschr; 1977 Sep; 31(9):414-7. PubMed ID: 904575
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacotherapeutic action of a hypotensive preparation made of grey rauwolfia roots].
    Bazhenova NI
    Sov Med; 1975 Oct; (10):73-7. PubMed ID: 1209332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.